June 2021: Additions and Deletions to the Drug Product List

June 2021: Additions and Deletions to the Drug Product List

Prescription and Over-the-Counter Drug Product List 41ST EDITION Cumulative Supplement Number 06 : June 2021 ADDITIONS/DELETIONS FOR PRESCRIPTION DRUG PRODUCT LIST ABIRATERONE ACETATE TABLET;ORAL ABIRATERONE ACETATE >A> AB QILU 500MG A 212462 002 Jun 25, 2021 Jun NEWA ACETAMINOPHEN; BUTALBITAL TABLET;ORAL BUTALBITAL AND ACETAMINOPHEN >A> AA ALVOGEN 300MG;50MG A 207635 001 Jun 05, 2017 Jun CAHN >A> AA 325MG;50MG A 205120 001 Oct 30, 2015 Jun CAHN >D> AA CNTY LINE PHARMS 300MG;50MG A 207635 001 Jun 05, 2017 Jun CAHN >D> AA 325MG;50MG A 205120 001 Oct 30, 2015 Jun CAHN ACETAMINOPHEN; BUTALBITAL; CAFFEINE TABLET;ORAL BUTALBITAL, ACETAMINOPHEN AND CAFFEINE >A> AA ALVOGEN 325MG;50MG;40MG A 204984 001 Jan 10, 2017 Jun CAHN >D> AA CNTY LINE PHARMS 325MG;50MG;40MG A 204984 001 Jan 10, 2017 Jun CAHN ACETAZOLAMIDE CAPSULE, EXTENDED RELEASE;ORAL ACETAZOLAMIDE >D> AB ! HERITAGE PHARMS INC 500MG A 090779 001 Jul 14, 2011 Jun CAHN >A> AB ! INDICUS PHARMA 500MG A 090779 001 Jul 14, 2011 Jun CAHN ACLIDINIUM BROMIDE; FORMOTEROL FUMARATE POWDER, METERED;INHALATION DUAKLIR PRESSAIR >D> ASTRAZENECA 0.4MG/INH;0.012MG/INH N 210595 001 Mar 29, 2019 Jun CHRS >A> +! 0.4MG/INH;0.012MG/INH N 210595 001 Mar 29, 2019 Jun CHRS ACYCLOVIR OINTMENT;TOPICAL ACYCLOVIR >D> AB ANDA REPOSITORY 5% A 206437 001 Jul 31, 2017 Jun DISC >A> @ 5% A 206437 001 Jul 31, 2017 Jun DISC ACYCLOVIR SODIUM INJECTABLE;INJECTION ACYCLOVIR SODIUM >D> AP EXELA PHARMA EQ 50MG BASE/ML A 207919 001 Jun 17, 2020 Jun CAHN >A> AP NAMIGEN LLC EQ 50MG BASE/ML A 207919 001 Jun 17, 2020 Jun CAHN ALENDRONATE SODIUM TABLET;ORAL ALENDRONATE SODIUM >D> AB JUBILANT CADISTA EQ 5MG BASE A 090557 001 Feb 18, 2010 Jun DISC >A> @ EQ 5MG BASE A 090557 001 Feb 18, 2010 Jun DISC >D> AB EQ 10MG BASE A 090557 002 Feb 18, 2010 Jun DISC >A> @ EQ 10MG BASE A 090557 002 Feb 18, 2010 Jun DISC >D> AB EQ 35MG BASE A 090557 003 Feb 18, 2010 Jun DISC >A> @ EQ 35MG BASE A 090557 003 Feb 18, 2010 Jun DISC >D> AB EQ 70MG BASE A 090557 004 Feb 18, 2010 Jun DISC >A> @ EQ 70MG BASE A 090557 004 Feb 18, 2010 Jun DISC ALENDRONATE SODIUM; CHOLECALCIFEROL TABLET;ORAL FOSAMAX PLUS D >D> + MERCK EQ 70MG BASE;2,800 IU N 021762 001 Apr 07, 2005 Jun CAHN >D> +! EQ 70MG BASE;5,600 IU N 021762 002 Apr 26, 2007 Jun CAHN >A> + ORGANON EQ 70MG BASE;2,800 IU N 021762 001 Apr 07, 2005 Jun CAHN >A> +! EQ 70MG BASE;5,600 IU N 021762 002 Apr 26, 2007 Jun CAHN Page 1 of 21 ADDITIONS/DELETIONS FOR PRESCRIPTION DRUG PRODUCT LIST ALLOPURINOL TABLET;ORAL ALLOPURINOL >D> AB APOTEX INC 100MG A 077353 001 Sep 08, 2005 Jun CAHN >D> AB 300MG A 077353 002 Sep 08, 2005 Jun CAHN >A> AB CHARTWELL 100MG A 077353 001 Sep 08, 2005 Jun CAHN >A> AB 300MG A 077353 002 Sep 08, 2005 Jun CAHN ALPRAZOLAM TABLET;ORAL ALPRAZOLAM >D> AB MYLAN 0.25MG A 074215 001 Jan 27, 1994 Jun DISC >A> @ 0.25MG A 074215 001 Jan 27, 1994 Jun DISC >D> AB 0.5MG A 074215 002 Jan 27, 1994 Jun DISC >A> @ 0.5MG A 074215 002 Jan 27, 1994 Jun DISC >D> AB 1MG A 074215 003 Jan 27, 1994 Jun DISC >A> @ 1MG A 074215 003 Jan 27, 1994 Jun DISC >D> AB 2MG A 074215 004 Jan 27, 1994 Jun DISC >A> @ 2MG A 074215 004 Jan 27, 1994 Jun DISC AMINOCAPROIC ACID TABLET;ORAL AMINOCAPROIC ACID >A> AB EDENBRIDGE PHARMS 500MG A 212110 001 Jun 14, 2021 Jun NEWA AMITRIPTYLINE HYDROCHLORIDE TABLET;ORAL AMITRIPTYLINE HYDROCHLORIDE >D> AB MYLAN 10MG A 086009 002 Apr 26, 1978 Jun DISC >A> @ 10MG A 086009 002 Apr 26, 1978 Jun DISC >D> AB 25MG A 086009 003 Apr 10, 1978 Jun DISC >A> @ 25MG A 086009 003 Apr 10, 1978 Jun DISC >D> AB 50MG A 086009 001 Apr 10, 1978 Jun DISC >A> @ 50MG A 086009 001 Apr 10, 1978 Jun DISC >D> AB 75MG A 086009 004 Apr 10, 1978 Jun DISC >A> @ 75MG A 086009 004 Apr 10, 1978 Jun DISC >D> AB 100MG A 086009 005 Apr 26, 1978 Jun DISC >A> @ 100MG A 086009 005 Apr 26, 1978 Jun DISC >D> AB 150MG A 086009 006 Apr 26, 1978 Jun DISC >A> @ 150MG A 086009 006 Apr 26, 1978 Jun DISC AMLODIPINE BESYLATE; OLMESARTAN MEDOXOMIL TABLET;ORAL AMLODIPINE AND OLMESARTAN MEDOXOMIL >D> AB JUBILANT GENERICS EQ 5MG BASE;20MG A 207450 001 May 15, 2017 Jun DISC >A> @ EQ 5MG BASE;20MG A 207450 001 May 15, 2017 Jun DISC >D> AB EQ 5MG BASE;40MG A 207450 002 May 15, 2017 Jun DISC >A> @ EQ 5MG BASE;40MG A 207450 002 May 15, 2017 Jun DISC >D> AB EQ 10MG BASE;20MG A 207450 003 May 15, 2017 Jun DISC >A> @ EQ 10MG BASE;20MG A 207450 003 May 15, 2017 Jun DISC >D> AB EQ 10MG BASE;40MG A 207450 004 May 15, 2017 Jun DISC >A> @ EQ 10MG BASE;40MG A 207450 004 May 15, 2017 Jun DISC AMOXICILLIN CAPSULE;ORAL AMOXICILLIN >D> AB BELCHER PHARMS 250MG A 062058 001 Aug 03, 1978 Jun CAHN >D> AB 500MG A 062058 002 Aug 03, 1978 Jun CAHN >A> AB CHARTWELL 250MG A 062058 001 Aug 03, 1978 Jun CAHN >A> AB 500MG A 062058 002 Aug 03, 1978 Jun CAHN AMPHETAMINE SULFATE TABLET;ORAL AMPHETAMINE SULFATE >D> AA GLENMARK PHARMS LTD 5MG A 212186 001 Jan 27, 2021 Jun DISC >A> @ 5MG A 212186 001 Jan 27, 2021 Jun DISC >D> AA 10MG A 212186 002 Jan 27, 2021 Jun DISC >A> @ 10MG A 212186 002 Jan 27, 2021 Jun DISC Page 2 of 21 ADDITIONS/DELETIONS FOR PRESCRIPTION DRUG PRODUCT LIST APREMILAST TABLET;ORAL APREMILAST >A> AB AMNEAL 10MG A 211782 001 Jun 30, 2021 Jun NEWA >A> AB 20MG A 211782 002 Jun 30, 2021 Jun NEWA >A> AB 30MG A 211782 003 Jun 30, 2021 Jun NEWA ARFORMOTEROL TARTRATE SOLUTION;INHALATION >A> ARFORMOTEROL TARTRATE >A> AN AXAR PHARMS INC EQ 0.015MG BASE/2ML A 213762 001 Jun 22, 2021 Jun NFTG >A> AN CIPLA EQ 0.015MG BASE/2ML A 207306 001 Jun 22, 2021 Jun NFTG >A> AN GLENMARK PHARMS LTD EQ 0.015MG BASE/2ML A 213132 001 Jun 22, 2021 Jun NFTG ARGATROBAN SOLUTION;INTRAVENOUS ARGATROBAN IN SODIUM CHLORIDE >A> +! ACCORD HLTHCARE 50MG/50ML (1MG/ML) N 212035 001 Jun 07, 2021 Jun NEWA AVAPRITINIB TABLET;ORAL AYVAKIT >A> + BLUEPRINT MEDICINES 25MG N 212608 004 Jun 16, 2021 Jun NEWA >A> + 50MG N 212608 005 Jun 16, 2021 Jun NEWA BACITRACIN >D> INJECTABLE;INJECTION >D> BACITRACIN >D> ! XELLIA PHARMS APS 50,000 UNITS/VIAL A 203177 001 Aug 25, 2014 Jun DISC >A> @ 50,000 UNITS/VIAL A 203177 001 Aug 25, 2014 Jun DISC BACLOFEN TABLET;ORAL BACLOFEN >A> AB IMPAX 5MG A 077971 003 Jul 07, 2021 Jun NEWA >A> AB 10MG A 077971 001 Oct 26, 2007 Jun CAHN >A> AB 20MG A 077971 002 Oct 26, 2007 Jun CAHN >D> AB IMPAX LABS 10MG A 077971 001 Oct 26, 2007 Jun CAHN >D> AB 20MG A 077971 002 Oct 26, 2007 Jun CAHN >A> BRINCIDOFOVIR >A> SUSPENSION;ORAL >A> TEMBEXA >A> +! CHIMERIX 10MG/ML N 214460 001 Jun 04, 2021 Jun NEWA >A> TABLET;ORAL >A> TEMBEXA >A> +! CHIMERIX 100MG N 214461 001 Jun 04, 2021 Jun NEWA >A> BUPIVACAINE; MELOXICAM >A> SOLUTION, EXTENDED RELEASE;PERIARTICULAR >A> ZYNRELEF KIT >A> +! HERON THERAPS INC 60MG/2.3ML N 211988 001 May 12, 2021 Jun NEWA (29.25MG/ML);1.8MG/2.3ML >A> +! 200MG/7ML (29.25MG/ML);6MG/7ML N 211988 002 May 12, 2021 Jun NEWA (0.88MG/ML) >A> +! 300MG/10.5ML N 211988 003 May 12, 2021 Jun NEWA (29.25MG/ML);9MG/10.5ML >A> +! 400MG/14ML N 211988 004 May 12, 2021 Jun NEWA (29.25MG/ML);12MG/14ML BUPRENORPHINE FILM, EXTENDED RELEASE;TRANSDERMAL BUPRENORPHINE >A> AB WATSON LABS TEVA 7.5MCG/HR A 204937 005 Jun 29, 2021 Jun NEWA BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE TABLET;SUBLINGUAL BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE >A> AB ALKEM LABS LTD EQ 2MG BASE;EQ 0.5MG BASE A 214930 001 Jun 15, 2021 Jun NEWA >A> AB EQ 8MG BASE;EQ 2MG BASE A 214930 002 Jun 15, 2021 Jun NEWA Page 3 of 21 ADDITIONS/DELETIONS FOR PRESCRIPTION DRUG PRODUCT LIST CALCIUM ACETATE TABLET;ORAL CALCIUM ACETATE >D> AB ! PADDOCK LLC 667MG A 091561 001 Apr 13, 2011 Jun CHRS >A> AB 667MG A 091561 001 Apr 13, 2011 Jun CHRS CALCIUM GLUCONATE SOLUTION;INTRAVENOUS CALCIUM GLUCONATE IN SODIUM CHLORIDE >A> +! HQ SPCLT PHARMA 1GM/100ML (10MG/ML) N 210906 003 Jun 04, 2021 Jun NEWA >D> CAPREOMYCIN SULFATE >D> INJECTABLE;INJECTION >D> CAPASTAT SULFATE >D> +! AKORN EQ 1GM BASE/VIAL N 050095 001 Jun 02, 1971 Jun DISC >A> + @ EQ 1GM BASE/VIAL N 050095 001 Jun 02, 1971 Jun DISC CARFILZOMIB POWDER;INTRAVENOUS >A> CARFILZOMIB >A> AP BRECKENRIDGE 10MG/VIAL A 209330 001 Jun 11, 2021 Jun NFTG >A> AP 60MG/VIAL A 209330 002 Jun 11, 2021 Jun NEWA CELECOXIB CAPSULE;ORAL CELECOXIB >D> AB ACIC PHARMS 200MG A 212925 001 Dec 09, 2020 Jun DISC >A> @ 200MG A 212925 001 Dec 09, 2020 Jun DISC >D> AB 400MG A 212925 002 Dec 09, 2020 Jun DISC >A> @ 400MG A 212925 002 Dec 09, 2020 Jun DISC >D> AB JUBILANT GENERICS 50MG A 207061 001 Apr 04, 2017 Jun DISC >A> @ 50MG A 207061 001 Apr 04, 2017 Jun DISC >D> AB 100MG A 207061 002 Apr 04, 2017 Jun DISC >A> @ 100MG A 207061 002 Apr 04, 2017 Jun DISC >D> AB 200MG A 207061 003 Apr 04, 2017 Jun DISC >A> @ 200MG A 207061 003 Apr 04, 2017 Jun DISC >D> AB 400MG A 207061 004 Apr 04, 2017 Jun DISC >A> @ 400MG A 207061 004 Apr 04, 2017 Jun DISC >D> @ YILING 50MG A 211412 001 Mar 06, 2020 Jun CMFD >A> AB 50MG A 211412 001 Mar 06, 2020 Jun CMFD >D> @ 100MG A 211412 002 Mar 06, 2020 Jun CMFD >A> AB 100MG A 211412 002 Mar 06, 2020 Jun CMFD >D> @ 200MG A 211412 003 Mar 06, 2020 Jun CMFD >A> AB 200MG A 211412 003 Mar 06, 2020 Jun CMFD >D> @ 400MG A 211412 004 Mar 06, 2020 Jun CMFD >A> AB 400MG A 211412 004 Mar 06, 2020 Jun CMFD CHOLINE FENOFIBRATE CAPSULE, DELAYED RELEASE;ORAL FENOFIBRIC ACID >D> AB YICHANG HUMANWELL EQ 45MG FENOFIBRIC ACID A 212562 001 Dec 23, 2020 Jun DISC >A> @ EQ 45MG FENOFIBRIC ACID A 212562 001 Dec 23, 2020 Jun DISC >D> AB EQ 135MG FENOFIBRIC ACID A 212562 002 Dec 23, 2020 Jun DISC >A> @ EQ 135MG FENOFIBRIC ACID A 212562 002 Dec 23, 2020 Jun DISC CICLOPIROX GEL;TOPICAL CICLOPIROX >A> AB +! ALVOGEN 0.77% N 020519 001 Jul 21, 1997 Jun CAHN >D> AB +! CNTY LINE PHARMS 0.77% N 020519 001 Jul 21, 1997 Jun CAHN CIPROFLOXACIN INJECTABLE, SUSPENSION;OTIC OTIPRIO >A> +! ALK

View Full Text

Details

  • File Type
    pdf
  • Upload Time
    -
  • Content Languages
    English
  • Upload User
    Anonymous/Not logged-in
  • File Pages
    21 Page
  • File Size
    -

Download

Channel Download Status
Express Download Enable

Copyright

We respect the copyrights and intellectual property rights of all users. All uploaded documents are either original works of the uploader or authorized works of the rightful owners.

  • Not to be reproduced or distributed without explicit permission.
  • Not used for commercial purposes outside of approved use cases.
  • Not used to infringe on the rights of the original creators.
  • If you believe any content infringes your copyright, please contact us immediately.

Support

For help with questions, suggestions, or problems, please contact us